65,437 trials
Esophageal Cancer · Gastric Cancer
Primary: Overall Response Will be Characterized by the Patient's FDG-PET Scan — 11; 9 participants
Abdominal Obesity · Insulin Resistance · Hypertriglyceridemia
Primary: Change From Baseline in Phosphocreatine Recovery (ViPCr) at 6-months — 1.7; 1.6 mM/s — p=0.97
Gout
Primary: Percentage of Subjects Whose Last Three Serum Urate Levels Are <6.0 Milligram Per Deciliter (mg/dL) — 22.5; 33.5; 17.0 percentage of participants
Advance Care Planning
Primary: Proportion of Subjects Who Select Palliative Care Options — 31; 50; 47 percentage who select palliative care
Contraception
Primary: Mean Maximum Procedural Pain Scores — 55.3; 54.3 units on a scale
Diabetes · Platelet Function · Healthy
Primary: Percent Platelet Aggregation Induced by Arachidonic Acid — 80; 90; 60; 29 maximum percentage aggregation
Low Back Pain
Primary: Change From Baseline to Week 12 in Average Daily Pain Intensity Scores — 0.94; 1.59 units on a scale — p=0.0012
Dry Eye Syndromes · Rheumatoid Arthritis
Primary: Number of Participants Diagnosed With Rheumatoid Arthritis Also Found to Have Dry Eye Disease — 275 participants
Urinary Incontinence
Primary: Primary Efficacy: Demonstrate the Efficacy of the ProACT Device in Reducing Incontinence as Measured by the 24-hour Pad Weight at 18 Months Compared to Baseline. A…
Post Menopausal Osteoporosis
Primary: Relative Percent Change From Baseline in Mean Bone Mineral Density (BMD) of Lumbar Spine (L2-L4) at 12 Months — 3.8199; 5.0872; 4.8188 Percent Change — p=<0.001
Infertility, Female
Primary: Number of Retrieved Oocytes — 13.14; 10.29 Oocytes
Pain
Primary: Number of Responders — 1; 2; 0; 0 participants
Pain
Primary: Change in Patient Global Impression of Change — 0.19 units on a scale
Colorectal Cancer
Primary: To Achieve Target Vitamin D Level — 41 participants
Extrahepatic Bile Duct Cancer · Gallbladder Cancer
Primary: Progression-Free Survival — 51 percentage of participants